Health Products

JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: JAMP TELMISARTAN-HCT
Issue: Health products - Product quality
What to do: Consult your health care professional if you have any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandLotProduct NameMarket AuthorizationDosage FormStrength
JAMP TELMISARTAN-HCTEG22TCJ001JAMP TELMISARTAN-HCTDIN 02389940TabletTelmisartan 80 mg/ Hydrochlorothiazide 12.5 mg

Issue

Possible presence of tablets containing only the hydrochlorothiazide layer in the affected lot which may also result in a higher dosage than the labelled dose of 12.5 mg.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime